ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$8.21
-1.32%
Mkt Cap $1.97B
Analyst Ratings
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
Implied Upside
+174.1%
Consensus $22.50 vs current $8.21
NASDAQ·Healthcare·Biotechnology
$8.21
-1.32%
Mkt Cap $1.97B
Buy
3
Hold
1
Sell
0
Price Target (7 analysts)
$22.50
Range $21.00 – $24.00
+174.1%
Consensus $22.50 vs current $8.21